The global Dengue Testing Market has been growing rapidly and is expected to continue on a steady growth trajectory over the forecast period. Factors driving the demand for dengue testing kits include the rising prevalence of dengue worldwide, supportive government initiatives, advancements in healthcare technology, and a rapid increase in population.

Symptoms of dengue fever include high fever, severe muscle and joint pain, fatigue, vomiting, and skin rash. The rising focus on community involvement to control the spread of dengue is one of the factors driving market growth going forward.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/4255

However, the COVID-19 pandemic has had a significant impact on the market, with the disruption of global operations and the shutdown of many transportation systems impacting manufacturing activities and operations globally. The emergence of new variants of the virus and increased infection rates during lockdowns has further disrupted supply chains.

Key players in the Dengue Testing Market:

·         Abnova

·         Roche Molecular Systems

·         Abbott Laboratories

·         InBios International

·         NovaTec Immundiagnostica

·         Sub.PerkinElmer

·         Quest Diagnostics

·         Certest Biotec

·         OriGene Technologies

·         Thermo Fisher

·         Others

The market is driven by an increase in the number of dengue patients, which is expected to drive demand for diagnostic kits globally. Technological advancements, advanced healthcare services and treatments, and supportive government initiatives to promote awareness are also expected to open up more potential for growth. Manufacturers are focusing on developing point-of-care diagnostic kits that are quick, accurate, and simple to use, which further drives global dengue testing market growth. However, high testing kit costs, limited access to healthcare facilities in underdeveloped regions, and a lack of effective diagnostic tools and solutions are negatively impacting revenue growth in the dengue testing market.

The market is segmented into ELISA-based tests, RT-PCR-based tests, Dengue IgG/IgM Rapid Test, and others. The RT-PCR-based tests segment accounted for a significantly robust revenue share in 2020, attributed to the high efficacy of this test and the rising number of testing labs globally. The market is further segmented by end-use into hospitals, diagnostic centers, and others, with the hospitals segment expected to account for a steady revenue share due to the rising prevalence of dengue patients requiring timely observation, improved healthcare infrastructure, and availability of testing kits.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/4255

Based on regional analysis, the Asia Pacific dengue testing market is expected to account for the largest revenue share compared to other regional markets over the forecast period. This is attributed to rising prevalence of dengue fever in countries such as India and China, supportive government initiatives, technological advancements in healthcare, presence of large population, rising disposable income, and increasing healthcare spending.

Key companies in the global dengue market include Abnova, Roche Molecular Systems, Abbott Laboratories, InBios International, NovaTec Immundiagnostica, Sub.PerkinElmer, Quest Diagnostics, Certest Biotec, OriGene Technologies, Thermo Fisher, and others. Key companies are expanding their business and focusing on innovative strategies, including partnerships, mergers, acquisitions, and new product development to stay ahead of the competition and generate more revenue opportunities.

The report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2018 to 2028. The global dengue testing market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. The report also includes industry analysis and competitive landscape, company financials, and impact analysis.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/4255

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report